A randomized, controlled, phase 2 trial of nivolumab plus standard-dose or low-dose bevacizumab for recurrent glioblastoma (NAVAL)
Publication Date
6-1-2024
Presented At:
American Society of Clinical Oncology (ASCO) Annual Meeting
Citation
Ahluwalia, Manmeet and Ozair, Ahmad, "A randomized, controlled, phase 2 trial of nivolumab plus standard-dose or low-dose bevacizumab for recurrent glioblastoma (NAVAL)" (2024). All Publications. 5480.
https://scholarlycommons.baptisthealth.net/se-all-publications/5480